tradingkey.logo

IDEXX Laboratories Inc

IDXX

660.435USD

+8.165+1.25%
取引時間 ET15分遅れの株価
52.93B時価総額
59.15直近12ヶ月PER

IDEXX Laboratories Inc

660.435

+8.165+1.25%
詳細情報 IDEXX Laboratories Inc 企業名
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.
企業情報
企業コードIDXX
会社名IDEXX Laboratories Inc
上場日Jun 21, 1991
最高経営責任者「CEO」Mr. Andrew Emerson
従業員数11000
証券種類Ordinary Share
決算期末Jun 21
本社所在地One Idexx Drive
都市WESTBROOK
証券取引所NASDAQ Global Select Consolidated
United States of America
郵便番号04092-2041
電話番号12075560300
ウェブサイトhttps://www.idexx.com/
企業コードIDXX
上場日Jun 21, 1991
最高経営責任者「CEO」Mr. Andrew Emerson
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+60.39%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+112.86%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Independent Director
Independent Director
1.09K
+31.76%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+60.39%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
CAG Diagnostics recurring revenue
806.27M
80.75%
IDEXX VetLab consumables
344.78M
34.53%
Reference laboratory diagnostic and consulting services
344.41M
34.49%
Rapid assay products
84.03M
8.42%
Veterinary software, services and diagnostic imaging systems
81.58M
8.17%
Other
-662.63M
-66.37%
地域別USD
会社名
収益
比率
United States
654.86M
65.59%
Europe & Middle East & Africa (EMEA) (Region)
204.55M
20.49%
Asia Pacific
81.73M
8.19%
Canada
37.30M
3.74%
Latin America
19.99M
2.00%
事業別
地域別
事業別USD
会社名
収益
比率
CAG Diagnostics recurring revenue
806.27M
80.75%
IDEXX VetLab consumables
344.78M
34.53%
Reference laboratory diagnostic and consulting services
344.41M
34.49%
Rapid assay products
84.03M
8.42%
Veterinary software, services and diagnostic imaging systems
81.58M
8.17%
Other
-662.63M
-66.37%
株主
更新時刻: 16 hours ago
更新時刻: 16 hours ago
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
12.30%
BlackRock Institutional Trust Company, N.A.
6.63%
State Street Global Advisors (US)
4.56%
Fundsmith LLP
3.31%
Geode Capital Management, L.L.C.
3.08%
Other
70.12%
株主統計
株主統計
比率
The Vanguard Group, Inc.
12.30%
BlackRock Institutional Trust Company, N.A.
6.63%
State Street Global Advisors (US)
4.56%
Fundsmith LLP
3.31%
Geode Capital Management, L.L.C.
3.08%
Other
70.12%
種類
株主統計
比率
Investment Advisor
56.65%
Investment Advisor/Hedge Fund
30.88%
Research Firm
3.88%
Pension Fund
2.27%
Bank and Trust
2.04%
Hedge Fund
1.87%
Sovereign Wealth Fund
1.33%
Individual Investor
0.69%
Family Office
0.54%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
2277
79.81M
99.73%
-1.01M
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
2023Q2
2157
77.53M
93.40%
-1.56M
2023Q1
2158
77.14M
92.96%
-2.07M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
9.82M
12.21%
+146.37K
+1.51%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.44M
6.76%
+113.70K
+2.14%
Mar 31, 2025
State Street Global Advisors (US)
3.65M
4.54%
+12.32K
+0.34%
Mar 31, 2025
Fundsmith LLP
2.65M
3.29%
-14.52K
-0.55%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.41M
3%
+112.62K
+4.90%
Mar 31, 2025
Baron Capital Management, Inc.
2.06M
2.56%
+54.26K
+2.71%
Mar 31, 2025
T. Rowe Price Associates, Inc.
1.87M
2.33%
+824.75K
+78.91%
Mar 31, 2025
Invesco Capital Management (QQQ Trust)
1.66M
2.07%
-25.31K
-1.50%
Jun 30, 2025
Principal Global Investors (Equity)
1.13M
1.4%
+414.80K
+58.32%
Mar 31, 2025
William Blair & Company, L.L.C. (Research)
1.09M
1.36%
-14.24K
-1.29%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Wed, Aug 6
更新時刻: Wed, Aug 6
銘柄名
比率
ProShares Pet Care ETF
10.23%
First Trust Water ETF
4.7%
iShares U.S. Medical Devices ETF
4.5%
Nuveen ESG Mid-Cap Growth ETF
3.31%
Hennessy Sustainable ETF
3.24%
Adaptive Core ETF
2.29%
Invesco Raymond James SB-1 Equity ETF
2.14%
First Trust S&P 500 Economic Moat Index ETF
2.08%
Putnam Sustainable Future ETF
1.94%
SPDR S&P Health Care Equipment ETF
1.87%
詳細を見る
ProShares Pet Care ETF
比率10.23%
First Trust Water ETF
比率4.7%
iShares U.S. Medical Devices ETF
比率4.5%
Nuveen ESG Mid-Cap Growth ETF
比率3.31%
Hennessy Sustainable ETF
比率3.24%
Adaptive Core ETF
比率2.29%
Invesco Raymond James SB-1 Equity ETF
比率2.14%
First Trust S&P 500 Economic Moat Index ETF
比率2.08%
Putnam Sustainable Future ETF
比率1.94%
SPDR S&P Health Care Equipment ETF
比率1.87%
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
tradingkey.logo
tradingkey.logo
当社が提供する日中データはRefinitivより配信されており、同社の利用規約が適用されます。終値データ(過去・現在)についてもRefinitivより提供されています。全ての相場情報は現地取引所時間で表示されます。米国株式のリアルタイム最終取引価格はNasdaqを通じて報告された取引のみを反映しています。日中データは最低15分遅れ、または各取引所の要件に準じて遅延配信されます。
* 当コンテンツ(分析資料・取引戦略等)は第三者プロバイダーであるTrading Centralより提供されており、記載の見解は分析官の独立した評価及び判断に基づくものです。投資家個々の投資目的や財務状況は考慮されておりません。
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。
KeyAI